soul trial semaglutide trial: Oral demonstrates a 14% reduction in risk of major adverse CV events Semaglutide phase 3 SUSTAIN trials

Animal models of FM are used to study the underlying pathophysiology of the condition and to assess potential treatments

Hair growth takes time and consistency

Conception: MJP, HK, KK

Qualifying Comorbidities FDA labeling and clinical guidelines commonly recognize: Hypertension (blood pressure 130/80 or taking antihypertensive medication) Type 2 diabetes (HbA1c 6.5% or on glucose-lowering medication) Prediabetes (HbA1c 5.7-6.4% or impaired fasting glucose) Dyslipidemia (elevated LDL, low HDL, or elevated triglycerides) Obstructive sleep apnea (diagnosed via sleep study) Cardiovascular disease (prior MI, stroke, coronary artery disease) Non-alcoholic fatty liver disease / MASLD Polycystic ovary syndrome (PCOS) with metabolic features Osteoarthritis weight-bearing joints Insurance formularies may be stricter some require objective documentation (lab values, sleep study reports) rather than self-report

Every formula is developed with world-renowned experts and held to uncompromising standards for ingredients, sourcing, and testing